Web-based site provides access to the HeartCheck™ PEN by Canadians who are without easy access to pharmacies

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced a distribution agreement with Toronto-based PHARMACY.CA, for internet-based sales of the HeartCheck™ ECG PEN device.

The agreement designates PHARMACY.CA as an authorized retailer for the sale of the HeartCheck™ PEN in Canada. PHARMACY.CA has been providing Canadians with reliable solutions to purchase over-the-counter (OTC), prescription and specialty medical products found in conventional pharmacy stores without leaving their home, for the past 15 years.

“Certainly a pharmacy centric retail model has been identified as an important market channel for us,” noted Etienne Grima, CEO of CardioComm Solutions Inc. “There is a growing trend in consumers seeking tools that can help them monitor their own health. Increasingly, the pharmacist has become a trusted partner and often a first port of call for persons unsure if they should see their physician. Access to a device like the HeartCheck™ PEN through the local pharmacist adds an important new dimension of service that pharmacists can provide and a new measure of convenience for consumers who can now obtain this device through an online purchase.”

“CardioComm Solutions continues to implement its pharmacy-based retail sales strategy for the handheld HeartCheck™ PEN ECG device in Canada, with the roll out governed heavily by the pharmacy banner groups we are working with,” said Simi Grosman, a member of CardioComm Solutions’ Board of Directors. “Internet-based sales are an important part of this strategy and PHARMACY.CA is therefore a very logical choice and synergistic partner for us.”  

The Company reports that the timing and selection of locations where the HeartCheck™ PEN product will be made available will be a phased process. During this time, PHARMACY.CA will provide a trusted, web-based sales opportunity with no timing barriers.

As the pharmacy banner role out occurs, availability of the HeartCheck™ PEN through PHARMACY.CA will complement the process and allow people who see the device advertised as a pharmacy OTC item, to purchase the HeartCheck™ PEN online should their local pharmacy not have the  HeartCheck™ PEN on the store shelf. This might often be the case in rural/satellite communities who will now be able to purchase the device online and then proceed to have their ECG read by a doctor or technician from a remote location using the Company’s patent pending SMART Monitoring ECG service.

“We are very interested in adding the HeartCheck™ PEN ECG device to our online products. This represents a new and innovative home-health monitoring solution that we believe will be of interest to our national customer base. With the planned promotion of the device likely to focus on large urban pharmacy operations, PHARMACY.CA will be able to expand access to those Canadians who may not be provided an opportunity to make a purchase at a local pharmacy,” added Scott Leslie, President of PHARMACY.CA.